Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients

The purposes of this study were to review utilization of insulin therapy in type 2 diabetes mellitus out patients and identify its drug related problems. The data were collected cross-sectionally with purposive sampling method in the period March 2016 until May 2016 in Outpatient Clinic Universitas...

Full description

Bibliographic Details
Main Authors: Budi Suprapti, Nia Widyasari, Mahardian Rahmadi, Cahyo Wibisono
Format: Article
Language:English
Published: Universitas Gadjah Mada 2017-10-01
Series:Indonesian Journal of Pharmacy
Subjects:
Online Access:http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1273/855
_version_ 1818959740269494272
author Budi Suprapti
Nia Widyasari
Mahardian Rahmadi
Cahyo Wibisono
author_facet Budi Suprapti
Nia Widyasari
Mahardian Rahmadi
Cahyo Wibisono
author_sort Budi Suprapti
collection DOAJ
description The purposes of this study were to review utilization of insulin therapy in type 2 diabetes mellitus out patients and identify its drug related problems. The data were collected cross-sectionally with purposive sampling method in the period March 2016 until May 2016 in Outpatient Clinic Universitas Airlangga Teaching Hospital Surabaya. The results of 240 patients showed that insulin was used as monotherapy insulin in 2,9% patients; combination 1 insulin & 1-4 OAD in 31,3%; basal bolus therapy 27,9%; combination basal−bolus therapy & 1-3 OAD 43,9%. Based on blood glucose target achievement, only 20,8% of patients achieve the target, 75,1% failed to achieve the target and 4,1% suffered from hypoglycemia. Drug related problems identified adverse drug reaction of antidiabetic therapy such as hypoglycemia (6.7%), nausea (3.8%), bloating (1.3%), increase of flatulency (2.9%) and inappropriate combination (0,4%). In conclusion insulin therapy was complicated and individually, most of the patients still did not reach the target and there was potential drug related problem in this patients group. So that caring from solid inter-professional health collaboration is needed
first_indexed 2024-12-20T11:46:26Z
format Article
id doaj.art-8aecf29c24de4cddba54c219147215fe
institution Directory Open Access Journal
issn 2338-9427
2338-9486
language English
last_indexed 2024-12-20T11:46:26Z
publishDate 2017-10-01
publisher Universitas Gadjah Mada
record_format Article
series Indonesian Journal of Pharmacy
spelling doaj.art-8aecf29c24de4cddba54c219147215fe2022-12-21T19:41:51ZengUniversitas Gadjah MadaIndonesian Journal of Pharmacy2338-94272338-94862017-10-01284221231http://dx.doi.org/10.14499/indonesianjpharm28iss4pp221Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory PatientsBudi Suprapti0Nia Widyasari1Mahardian Rahmadi2Cahyo Wibisono3Faculty of Pharmacy Universitas Airlangga, Jl. Dharmawangsa No 4-6, Surabaya, IndonesiaFaculty of Pharmacy Universitas Airlangga, Jl. Dharmawangsa No 4-6, Surabaya, IndonesiaUniversitas Airlangga Teaching Hospital, Jalan Mulyorejo, Surabaya, Indonesia2Faculty of Medicine Universitas Airlangga, Jalan Dr. Moestopo, Surabaya, IndoensiaThe purposes of this study were to review utilization of insulin therapy in type 2 diabetes mellitus out patients and identify its drug related problems. The data were collected cross-sectionally with purposive sampling method in the period March 2016 until May 2016 in Outpatient Clinic Universitas Airlangga Teaching Hospital Surabaya. The results of 240 patients showed that insulin was used as monotherapy insulin in 2,9% patients; combination 1 insulin & 1-4 OAD in 31,3%; basal bolus therapy 27,9%; combination basal−bolus therapy & 1-3 OAD 43,9%. Based on blood glucose target achievement, only 20,8% of patients achieve the target, 75,1% failed to achieve the target and 4,1% suffered from hypoglycemia. Drug related problems identified adverse drug reaction of antidiabetic therapy such as hypoglycemia (6.7%), nausea (3.8%), bloating (1.3%), increase of flatulency (2.9%) and inappropriate combination (0,4%). In conclusion insulin therapy was complicated and individually, most of the patients still did not reach the target and there was potential drug related problem in this patients group. So that caring from solid inter-professional health collaboration is neededhttp://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1273/855Diabetes mellitusinsulinambulatory patientDURDRP
spellingShingle Budi Suprapti
Nia Widyasari
Mahardian Rahmadi
Cahyo Wibisono
Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
Indonesian Journal of Pharmacy
Diabetes mellitus
insulin
ambulatory patient
DUR
DRP
title Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
title_full Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
title_fullStr Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
title_full_unstemmed Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
title_short Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients
title_sort review of insulin therapy in type 2 diabetes mellitus ambulatory patients
topic Diabetes mellitus
insulin
ambulatory patient
DUR
DRP
url http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/1273/855
work_keys_str_mv AT budisuprapti reviewofinsulintherapyintype2diabetesmellitusambulatorypatients
AT niawidyasari reviewofinsulintherapyintype2diabetesmellitusambulatorypatients
AT mahardianrahmadi reviewofinsulintherapyintype2diabetesmellitusambulatorypatients
AT cahyowibisono reviewofinsulintherapyintype2diabetesmellitusambulatorypatients